|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.86 USD | +0.40% |
|
-0.64% | +6.62% |
| 09:29am | Leerink Partners Adjusts Gilead Sciences Price Target to $126 From $127, Maintains Market Perform Rating | MT |
| Jul. 22 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| Market Cap | 162B 142B 132B 122B 228B 15,672B 232B 1,581B 617B 7,644B 608B 594B 26,519B | P/E 2026 * |
-47x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 171B 151B 140B 129B 241B 16,588B 246B 1,674B 653B 8,091B 643B 629B 28,069B | EV / Sales 2026 * |
5.63x | EV / Sales 2027 * | 5.01x |
| Free-Float |
99.88% | Yield 2026 * |
2.53% | Yield 2027 * | 2.62% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.40% | ||
| 1 week | -0.64% | ||
| Current month | +3.58% | ||
| 1 month | +4.80% | ||
| 3 months | -1.53% | ||
| 6 months | -0.21% | ||
| Current year | +6.62% |
| 1 week | 127.61 |  | 140.61 |
| 1 month | 123.67 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 7/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | -0.64% | +18.78% | +62.28% | 162B | |
| +1.97% | +2.53% | +52.73% | +156.66% | 1,037B | |
| +1.42% | +4.96% | +54.39% | +52.34% | 615B | |
| +1.43% | +5.25% | +37.31% | +78.74% | 448B | |
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | |
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | +3.68% | +21.53% | +58.21% | 198B | |
| +0.77% | +0.77% | -0.52% | -33.13% | 141B | |
| Average | +1.48% | +1.01% | +25.84% | +41.78% | 369.89B | |
| Weighted average by Cap. | +1.58% | +1.42% | +36.84% | +71.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.42B 26.76B 24.86B 22.86B 42.87B 2,946B 43.64B 297B 116B 1,437B 114B 112B 4,985B | 32.28B 28.39B 26.38B 24.26B 45.49B 3,126B 46.31B 315B 123B 1,525B 121B 119B 5,290B |
| Net income | -3.39B -2.98B -2.77B -2.55B -4.78B -328B -4.86B -33.13B -12.92B -160B -12.73B -12.46B -556B | 9.76B 8.59B 7.98B 7.34B 13.76B 945B 14B 95.38B 37.2B 461B 36.65B 35.86B 1,600B |
| Net Debt | 9.46B 8.32B 7.73B 7.11B 13.33B 916B 13.57B 92.43B 36.05B 447B 35.52B 34.75B 1,550B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | $130.86 | +0.40% | 6,297,169 |
| 26-07-22 | $130.34 | +0.05% | 4,757,764 |
| 26-07-21 | $130.28 | -2.20% | 8,371,109 |
| 26-07-20 | $133.21 | -0.80% | 4,103,979 |
| 26-07-17 | $134.28 | -1.48% | 6,903,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
